Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Dec 9, 2025 · Filed Dec 10, 2025
A board member of Hims & Hers Health sold $98K of Hims & Hers Health shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$97,925
Shares × reported transaction price
36 days after results of Nov 3, 2025, 76 days before results of Feb 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −7.9% | −1.8% | −6.1% |
| 30 days | −14.4% | +0.9% | −15.3% |
| 90 days | −31.5% | −1.9% | −29.6% |
| 180 days | −23.3% | +7.0% | −30.2% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
CFO sold ~$306K of Hims & Hers Health
Scheduled in advance